Associations - ABL1 T315I

BIOMARKER:

ABL1 T315I

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

ABL1 T315I ABL1 T315I	Chronic Myeloid Leukemia CML	ponatinib Sensitive: A1 - Approval ponatinib Sensitive : A1
ABL1 T315I ABL1 T315I	Acute Lymphocytic Leukemia ALL	ponatinib Sensitive: A2 - Guideline ponatinib Sensitive : A2
ABL1 T315I ABL1 T315I	Chronic Myeloid Leukemia CML	dasatinib Resistant: C3 – Early Trials dasatinib Resistant : C3
ABL1 T315I ABL1 T315I	Acute Lymphocytic Leukemia ALL	dasatinib Resistant: C4 – Case Studies dasatinib Resistant : C4
ABL1 T315I ABL1 T315I	Acute Lymphocytic Leukemia ALL	imatinib Resistant: C4 – Case Studies imatinib Resistant : C4